Status:
COMPLETED
Remote Ischemic Conditioning in HSCT
Lead Sponsor:
Children's Hospital Medical Center, Cincinnati
Conditions:
Hematopoietic Stem Cell Transplantations
Eligibility:
All Genders
10+ years
Phase:
NA
Brief Summary
This is a feasibility study at a single site, Cincinnati Children's Hospital Medical Center. The hypothesis will be tested using a prospective study design. The purpose of the study is to determine to...
Eligibility Criteria
Inclusion
- Pediatric, adolescent, or young adult patients, 10 years of age or above.
- Able to tolerate upper arm blood pressure inflation.
- Participating in the BMT Biorepository (2012-1156).
Exclusion
- Systolic blood pressure \>160 mmHg.
- Previous diagnosis of cardiomyopathy (dilated, hypertrophic, restrictive, myocarditis) or congenital heart disease other than bicuspid aortic valve.
- Chronic kidney disease as defined as a pre-transplant GFR \<80
- Central line in both upper extremities.
- Known peripheral vascular disease or vasculitis.
- Platelet count less than 30,000.
- Known clotting disorder or hypercoagulability
- Non-English speaking patients.
Key Trial Info
Start Date :
August 21 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 21 2024
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT04808167
Start Date
August 21 2018
End Date
March 21 2024
Last Update
May 2 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cincinnati Children's Hospital
Cincinnati, Ohio, United States, 45229